Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

Cited In for PubMed (Select 21220330)

1.

The tyrosine phosphatase SHP2 associates with CUB domain-containing protein-1 (CDCP1), regulating its expression at the cell surface in a phosphorylation-dependent manner.

Gandji LY, Proust R, Larue L, Gesbert F.

PLoS One. 2015 Apr 13;10(4):e0123472. doi: 10.1371/journal.pone.0123472. eCollection 2015.

2.
3.

CDCP1 identifies a CD146 negative subset of marrow fibroblasts involved with cytokine production.

Iwata M, Torok-Storb B, Wayner EA, Carter WG.

PLoS One. 2014 Oct 2;9(10):e109304. doi: 10.1371/journal.pone.0109304. eCollection 2014.

4.

Characterization of functional reprogramming during osteoclast development using quantitative proteomics and mRNA profiling.

An E, Narayanan M, Manes NP, Nita-Lazar A.

Mol Cell Proteomics. 2014 Oct;13(10):2687-704. doi: 10.1074/mcp.M113.034371. Epub 2014 Jul 20.

5.

Identification of CDCP1 as a hypoxia-inducible factor 2α (HIF-2α) target gene that is associated with survival in clear cell renal cell carcinoma patients.

Emerling BM, Benes CH, Poulogiannis G, Bell EL, Courtney K, Liu H, Choo-Wing R, Bellinger G, Tsukazawa KS, Brown V, Signoretti S, Soltoff SP, Cantley LC.

Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3483-8. doi: 10.1073/pnas.1222435110. Epub 2013 Feb 1.

6.

Structural requirements for cub domain containing protein 1 (CDCP1) and Src dependent cell transformation.

Kollmorgen G, Bossenmaier B, Niederfellner G, Häring HU, Lammers R.

PLoS One. 2012;7(12):e53050. doi: 10.1371/journal.pone.0053050. Epub 2012 Dec 31.

7.

In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling.

Casar B, Rimann I, Kato H, Shattil SJ, Quigley JP, Deryugina EI.

Oncogene. 2014 Jan 9;33(2):255-68. doi: 10.1038/onc.2012.547. Epub 2012 Dec 3.

8.

Quantitative proteomics with siRNA screening identifies novel mechanisms of trastuzumab resistance in HER2 amplified breast cancers.

Boyer AP, Collier TS, Vidavsky I, Bose R.

Mol Cell Proteomics. 2013 Jan;12(1):180-93. doi: 10.1074/mcp.M112.020115. Epub 2012 Oct 25.

9.

Cell surface remodeling by plasmin: a new function for an old enzyme.

Deryugina EI, Quigley JP.

J Biomed Biotechnol. 2012;2012:564259. doi: 10.1155/2012/564259. Epub 2012 Oct 14. Review.

10.

Involvement of Src in the Adaptation of Cancer Cells under Microenvironmental Stresses.

Mahbub Hasan AK, Ijiri T, Sato K.

J Signal Transduct. 2012;2012:483796. doi: 10.1155/2012/483796. Epub 2012 Sep 3.

11.

The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain.

Lamar JM, Stern P, Liu H, Schindler JW, Jiang ZG, Hynes RO.

Proc Natl Acad Sci U S A. 2012 Sep 11;109(37):E2441-50. doi: 10.1073/pnas.1212021109. Epub 2012 Aug 13.

12.

Glucocorticoids and histone deacetylase inhibitors cooperate to block the invasiveness of basal-like breast cancer cells through novel mechanisms.

Law ME, Corsino PE, Jahn SC, Davis BJ, Chen S, Patel B, Pham K, Lu J, Sheppard B, Nørgaard P, Hong J, Higgins P, Kim JS, Luesch H, Law BK.

Oncogene. 2013 Mar 7;32(10):1316-29. doi: 10.1038/onc.2012.138. Epub 2012 Apr 30.

13.

Anoikis resistance: an essential prerequisite for tumor metastasis.

Kim YN, Koo KH, Sung JY, Yun UJ, Kim H.

Int J Cell Biol. 2012;2012:306879. doi: 10.1155/2012/306879. Epub 2012 Feb 23.

14.

KAI1 suppresses HIF-1α and VEGF expression by blocking CDCP1-enhanced Src activation in prostate cancer.

Park JJ, Jin YB, Lee YJ, Lee JS, Lee YS, Ko YG, Lee M.

BMC Cancer. 2012 Mar 6;12:81. doi: 10.1186/1471-2407-12-81.

15.

The cell surface glycoprotein CUB domain-containing protein 1 (CDCP1) contributes to epidermal growth factor receptor-mediated cell migration.

Dong Y, He Y, de Boer L, Stack MS, Lumley JW, Clements JA, Hooper JD.

J Biol Chem. 2012 Mar 23;287(13):9792-803. doi: 10.1074/jbc.M111.335448. Epub 2012 Feb 7.

16.

Blocking of CDCP1 cleavage in vivo prevents Akt-dependent survival and inhibits metastatic colonization through PARP1-mediated apoptosis of cancer cells.

Casar B, He Y, Iconomou M, Hooper JD, Quigley JP, Deryugina EI.

Oncogene. 2012 Aug 30;31(35):3924-38. doi: 10.1038/onc.2011.555. Epub 2011 Dec 19.

17.

Cellular settings mediating Src Substrate switching between focal adhesion kinase tyrosine 861 and CUB-domain-containing protein 1 (CDCP1) tyrosine 734.

Wortmann A, He Y, Christensen ME, Linn M, Lumley JW, Pollock PM, Waterhouse NJ, Hooper JD.

J Biol Chem. 2011 Dec 9;286(49):42303-15. doi: 10.1074/jbc.M111.227462. Epub 2011 Oct 12.

18.

The SRC-associated protein CUB Domain-Containing Protein-1 regulates adhesion and motility.

Benes CH, Poulogiannis G, Cantley LC, Soltoff SP.

Oncogene. 2012 Feb 2;31(5):653-63. doi: 10.1038/onc.2011.262. Epub 2011 Jul 4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk